Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical ...
GlobalData on MSN
Precision begins patient enrolment for FUNCTION-DMD trial
PBGENE-DMD aims to deliver sustained muscle function improvement for DMD patients with mutations between exons 45 and 55.
Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene April 29, ...
PowerHome is a manufacturer and global supplier of power conversion equipment, specializing in single-phase and three-phase ...
EPC’s evaluation kit for a three-phase inverter platform based on its Gen-7 EPC2366 eGaN power transistor streamlines motor ...
The Phase 1/2 FUNCTION-DMD study will enroll ambulatory patients and is designed to evaluate safety, tolerability, and efficacy, including dystrophin protein expression and functional outcomes. "The ...
MusicRadar on MSN
We pit 5 of the best soft synths against each other
We put five of today's most powerful, flexible and versatile synth plugins to the test to find out who comes out on top ...
Researchers at Skoltech have developed an ultra-compact electro-optic modulator based on silicon photonics and plasmonics ...
Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical stage biotechnology company developing next-generation ...
Polytec's optical measurement equipment focuses on dynamic response measurements. MEMS devices typically have actively moving ...
A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...
Researchers led by Professor Ting Mei (Northwestern Polytechnical University) and Professors Xiaocong Yuan & Yuquan Zhang ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results